This study investigated light emitting diode (LED) treatment for patients with melasma on darker skin types.
Background:
Melasma is a common disfiguring skin condition in women which is difficult to treat and is refractory. The cause of melasma remains unclear.
Methods:
In this study, 60 female participants aged between 25 and 60 years, who presented with melasma, were enrolled (n = 39.85). They were purposely assigned to two groups according to their skin types. Both groups received a total of 36 LED light treatments over a period of 9 months.
Results:
Both subjective and objective results indicated a significant improvement of melasma. Statistical analyses revealed significant improvements in both groups.
Conclusions:
The results of this study suggest that LED is effective in managing melasma. These results will provide a basis for future therapeutic use of phototherapy to improve melasma.
Get full access to this article
View all access options for this article.
References
1.
HandelAC, LimaPB, TonolliVM, MiotLD, MiotHA. Risk factors for facial melasma in women: a case–control study. Br J Dermatol, 2014; 171:588–594.
HalderRM, RodneyIJ. Why are there so few effective treatments for pigmentary disorders of the skin?. Exp Rev Dermatol, 2012; 7:109–112.
4.
AliR, AmanS, NadeemM, KazmiAH. Quality of life in participants of melasma. J Pak Assoc Dermatol, 2016; 23:143–148.
5.
MachekposhtiSA, SoltaniM, NajafizadehP, EbrahimiSA, ChenP. Biocompatible polymer microneedle for topical/dermal delivery of tranexamic acid. J Control Release, 2017; 261:87–92.
6.
WuS, ShiH, WuH, et al.Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plast Surg, 2012; 36:964–970.
7.
SinghR, GoyalS, AhmedQR, GuptaN, SinghS. Effect of 82% lactic acid in treatment of melasma. Int Sch Res Notices, 2014; 2014:407142.
8.
GuinotC, CheffaiS, LatreilleJ, et al.Aggravating factors for melasma: a prospective study in 197 Tunisian participants. J Eur Acad Dermatol Venereol, 2010; 24:1060–1069.
9.
ArdigoM, CameliN, BerardescaE, GonzalezS. Characterization and evaluation of pigment distribution and response to therapy in melasma using in vivo reflectance confocal microscopy: a preliminary study. J Eur Acad Dermatol Venereol, 2010; 24:1296–1303.
10.
LeeSY, ParkKH, ChoiJW, et al.Prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation: clinical, profilometric, histologic, ultrastructural, and biochemical evaluations and comparison of three different treatment settings. J Photochem Photobiol Biol, 2007; 88:51–67.
11.
DiBernardoBE, PoznerJN (eds.). Lasers and Non-Surgical Rejuvenation. Techniques in Aesthetic Plastic Surgery. New York: Saunders ELSEVIER, 2009:65–69.
12.
RussellBA, KellettN, ReillyLR. A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation. J Cosmet Laser Ther, 2005; 7:196–200.
13.
WeissRA, McDanielDH, GeronemusRG, WeissMA. Clinical trial of a novel non‐thermal LED array for reversal of photoaging: clinical, histologic, and surface profilometric results. Lasers Surg Med, 2005; 36:85–91.
14.
PapageorgiouP, KatsambasA, ChuA. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol, 2000; 142:973–978.
Omnilux User Guide, 2018 (online). Available at: http://lifvation.com/omnilux/materials/ProtocolBooklet.pdf (Last accessed March2, 2017).
17.
D'EliaMP, BrandãoMC, de Andrade RamosBR, et al.African ancestry is associated with facial melasma in women: a cross-sectional study. BMC Med Genet, 2017; 18:17.
18.
YalamanchiliR, ShastryV, BetkerurJ. Clinico-epidemiological study and quality of life assessment in melasma. Indian J Dermatol, 2015; 60:519.
19.
KrupaShankarDS, SomaniVK, KohliM, et al.A cross-sectional, multicentric clinico-epidemiological study of melasma in India. Dermatol Ther, 2014; 4:71–81.
20.
LeeyaphanC, WanitphakdeedechaR, ManuskiattiW, KulthananK. Measuring melasma participants' quality of life using willingness to pay and time trade-off methods in Thai population. BMC Dermatol, 2011; 11:16.
21.
GohCL, DlovaCN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J, 1999; 40:455–458.
22.
HexselD, LacerdaDA, CavalcanteAS, et al.Epidemiology of melasma in Brazilian participants: a multicenter study. Int J Dermatol, 2014; 53:440–444.
23.
ShethVM, PandyaAG. Melasma: a comprehensive update: part II. J Am Acad Dermatol, 2011; 65:699–714.
24.
DavisEC, CallenderVD. Post inflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthetic Dermatol, 2010; 3:20.
25.
SalamA, DadzieOE, GaladariH. Chemical peeling in ethnic skin: an update. Br J Dermatol, 2013; 169(Suppl 3):82–90.
26.
AcharA, RathiSK. Melasma: a clinico-epidemiological study of 312 cases. Indian J Dermatol, 2011; 56:380.
27.
GargS, SarkarR, PandyaAG. New Delhi: JP Medicals LTD. Melasma and Quality of Life. Melasma: A Monograph. 2015; 5:74–80.
28.
KarnD, KCS, AmatyaA, RazouriaEA, TimalsinaM, SuwalA. Q-Switched Neodymium-Doped Yttrium Aluminum Garnet laser therapy for pigmented skin lesions: efficacy and safety. Kathmandu Univ Med J, 2013; 10:46–50.
29.
AlamM, PongprutthipanM (eds.). Body Rejuvenation. New York: Springer, 2010:55–68.
30.
HamadiSA, MohammedMM, AljafAN, AbdulrazakA. The role of topical and oral melatonin in management of melasma participants. J Arab Univ Basic Appl Sci, 2009; 8:30–42.
31.
GuptaAK, GoverMD, NouriK, TaylorS. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol, 2006; 55:1048–1065.
32.
KatsambasAD, StratigosAJ, LottiTM. Melasma. In: European Handbook of Dermatological Treatments. Berlin, Heidelberg: Springer, 2003; pp. 336–341.
33.
GrimesPE. The safety and efficacy of salicylic acid chemical peels in darker racial‐ethnic groups. Dermatol Surg, 1999; 25:18–22.
34.
HalderRM, GrimesPE, McLaurinCI, KressMA, KenneyJAJr. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis, 1983; 32:388–390.
35.
LawsonCN, HollingerJ, SethiS, et al.Updates in the understanding and treatments of skin & hair disorders in women of color. Int J Womens Dermatol, 2017; 3:S21–S37.
36.
BariAU, RahmanSB. Pigmentary skin disorders in black Africans of Sierra Leon. J Pak Assoc Dermatol, 2016; 17:4–10.
37.
TshudukuGM, AnnandaleZF. Chemical peeling in ethnic skin. SADR, 2009; 9:34–37.
38.
RobertsWE. Chemical peeling in ethnic/dark skin. Dermatol Ther, 2004; 17:196–205.
39.
JohnstoneF.White Prosperity and White Supremacy in South Africa today. African Affairs, [online]. 1970:69; 124–140. Available at: http://dx.doi/org/10.1093/oxfordjournals.afraf.a095990 (Last accessed March2, 2017).
40.
MpofanaN, RamhurryC. An investigation into the effectiveness of light emitting diodes on treating melasma on skin type VI. Am J Dermatol Venereol, 2014; 3:51–56.
41.
MahmoudBH, RuvoloE, HexselCL, et al.Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol, 2010; 130:2092–2097.
42.
MahmoudBH, HexselCL, HamzaviIH, LimHW. Effects of visible light on the skin. Photochem Photobiol, 2008; 84:450–462.
43.
TarazM, NiknamS, EhsaniAH. Tranexamic acid in treatment of melasma: a comprehensive review of clinical studies. Dermatol Ther, 2017; 30:e12465.
44.
KwonSH, HwangYJ, LeeSK, ParkKC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci, 2016; 17:824.
45.
SialyR, HassanI, KaurI, DashRJ. Melasma in men: a hormonal profile. J Dermatol, 2000; 27:64–65.
SolanoF, BrigantiS, PicardoM, GhanemG. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res, 2006; 19:550–571.
53.
HaddadAL, MatosLF, BrunsteinF, FerreiraLM, SilvaA, CostaD. A clinical, prospective, randomized, double‐blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol, 2003; 42:153–156.
54.
SanchezNP, PathakMA, SatoS, FitzpatrickTB, SanchezJL, MihmMC. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol, 1981; 4:698–710.
55.
PathakMA. Clinical and Therapeutic Aspects of Melasma: An Overview. In: Brown Melanoderma. FitzpatrickTB, WickMM, TodaK (eds.). Tokyo, Japan: University of Tokyo Press, 1986; pp. 161–171.
56.
FuB, LiH, WangX, LeeFS, CuiS. Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase. J Agric Food Chem, 2005; 53:7408–7414.
57.
VictorFC, GelberJ, RaoB. Melasma: a review. J Cutan Med Surg, 2004; 8:97–102.
AccuWeather. 2017. South Africa weather. Available at: www.accuweather.com/en/za/South-Africa-weather (Last accessed September5, 2017).
60.
JungeKM, BauerT, GeisslerS, et al.Increased vitamin D levels at birth and in early infancy increase offspring allergy risk—evidence for involvement of epigenetic mechanisms. J Allergy Clin Immunol, 2016; 137:610–613.
61.
XueJ, SchoenrockSA, ValdarW, TarantinoLM, IderaabdullahFY. Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Clin Epigenetics, 2016; 8:107.
62.
BoukariF, JourdanE, FontasE, et al.Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol, 2015; 72:189–190.
63.
SuthantherCB, BubnaAK, SankarasubramanianA, VeeraraghavanM, RangarajanS, MuralidharK. A clinical study of melasma and assessment of Dermatology Life Quality Index at a tertiary health care center in South India. Pigment Int, 2016; 3:77.
64.
MajidI, HaqI, ImranS, KeenA, AzizK, ArifT. Proposing melasma severity index: a new, more practical, office-based scoring system for assessing the severity of melasma. Indian J Dermatol, 2016; 61:39.
65.
WeistenhöferW, BaumeisterT, DrexlerH, KüttingB. An overview of skin scores used for quantifying hand eczema: a critical update according to the criteria of evidence‐based medicine. Br J Dermatol, 2010; 162:239–250.
66.
KangHY, BahadoranP, SuzukiI, et al.In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution. Exp Dermatol, 2010; 19:228–233.
67.
RendonM, BerneburgM, ArellanoI, PicardoM. Treatment of melasma. J Am Acad Dermatol, 2006; 54:272–281.
68.
Espinal‐PerezLE, MoncadaB, Castanedo‐CazaresJP. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol, 2004; 43:604–607.
69.
SarkarR, KaurC, BhallaM, KanwarAJ. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark‐skinned participants: a comparative study. Dermatol Surg, 2002; 28:828–832.
70.
GuevaraIL, PandyaAG. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. Int J Dermatol, 2003; 42:966–972.
71.
AamirS, NaseemR. Oral tranexamic acid in treatment of melasma in Pakistani population: a pilot study. J Pak Assoc Dermatol, 2016; 24:198–203.
72.
NaJI, ChoiSY, YangSH, ChoiHR, KangHY, ParkKC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol, 2013; 27:1035–1039.
73.
LimJT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg, 1999; 25:282–284.
74.
SugawaraJ, KouS, KouS, YasumuraK, SatakeT, MaegawaJ. Influence of the frequency of laser toning for melasma on occurrence of leukoderma and its early detection by ultraviolet imaging. Lasers Surg Med, 2015; 47:161–167.
75.
PasseronT, FontasE, KangHY, BahadoranP, LacourJP, OrtonneJP. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study. Arch Dermatol, 2011; 147:1106–1108.
76.
PratchyapruitW, VashrangsiN, SindhavanandaJ, TagamiH. Instrumental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman–Willis triple combination therapy: confirmation by using its two different formulae. Skin Res Technol, 2011; 17:226–233.
77.
ChanNP, HoSG, ShekSY, YeungCK, ChanHH. A case series of facial depigmentation associated with low fluence q‐switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med, 2010; 42:712–719.
78.
SardesaiVR, KolteJN, SrinivasBN. A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment. Indian J Dermatol, 2013; 58:239.
79.
AsawanondaP, TaylorCR. Wood's light in dermatology. Int J Dermatol, 1999; 38:801–807.
80.
MpofanaN, AbrahamseH. Natural options for management of melasma, a review. J Cosmet Laser Ther, 2018; 20:1–12.
